Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04121780
PHASE2

Growth Hormone Replacement Therapy for Retried Professional Football Players

Sponsor: Center for Neurological Studies

View on ClinicalTrials.gov

Summary

This is a randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension to evaluate the efficacy of growth hormone (GH) on cognitive functions of retired professional football players with growth hormone deficiency (GHD).

Official title: Interventional Study of Growth Hormone Replacement Therapy in Retired Professional Football Players With Growth Hormone Deficiency

Key Details

Gender

MALE

Age Range

18 Years - 76 Years

Study Type

INTERVENTIONAL

Enrollment

42

Start Date

2019-10-08

Completion Date

2026-09

Last Updated

2023-02-08

Healthy Volunteers

No

Interventions

BIOLOGICAL

Growth Hormone

Daily self-injections by subjects: 1-year double-blind phase; 6-month open-label extension for those who received placebo during the double-blind phase

OTHER

Placebo

Daily self-injections by subjects: 1-year double-blind phase

Locations (1)

Center for Neurolgoical Studies (CNS)

Dearborn, Michigan, United States